A method for preparing an enone compound of formula (I) is disclosed. Furthermore, the enone compound of formula (I) obtained by the method may be used alone, or in combination with a washing agent, a cleaning agent, an insect repellant agent, a pharmaceutical agent, a fragrance, a pro-fragrance, or combinations thereof.

A method for preparing an enone compound of formula (I) is disclosed. Furthermore, the enone compound of formula (I) obtained by the method may be used alone, or in combination with a washing agent, a cleaning agent, an insect repellant agent, a pharmaceutical agent, a fragrance, a pro-fragrance, or combinations thereof.

Improved methods of treating multiple sclerosis and/or psoriasis using prodrugs of methyl hydrogen fumarate are disclosed. The methods comprise administering certain prodrugs of methyl hydrogen fumarate. The methods are able to achieve high blood plasma concentrations of the active metabolite, methyl hydrogen fumarate, without causing significant gastrointestinal irritation. New prodrugs of methyl hydrogen fumarate are also disclosed.

Improved methods of treating multiple sclerosis and/or psoriasis using prodrugs of methyl hydrogen fumarate are disclosed. The methods comprise administering certain prodrugs of methyl hydrogen fumarate. The methods are able to achieve high blood plasma concentrations of the active metabolite, methyl hydrogen fumarate, without causing significant gastrointestinal irritation. New prodrugs of methyl hydrogen fumarate are also disclosed.

Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.

Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.

Ionic liquids comprising the association of a cation have the following formula (I), in which R1 is an acyclic hydrocarbonated group, n is a whole number between 0 and 3, and m is a whole number between 1 and 4, and an anion selected from a nitrate anion, a phosphate anion or an imidide anion.

Ionic liquids comprising the association of a cation have the following formula (I), in which R1 is an acyclic hydrocarbonated group, n is a whole number between 0 and 3, and m is a whole number between 1 and 4, and an anion selected from a nitrate anion, a phosphate anion or an imidide anion.

The present invention is directed to a process for preparing a compound of formula I-11 through multiple-step reactions: ##STR00001##

The present invention is directed to a process for preparing a compound of formula I-11 through multiple-step reactions: ##STR00001##